←
Lisa Hicks2,511 posts
Lisa Hicks avatar

Lisa Hicks

@LisaHicksMD

Myeloma/lymphoma doc. Caring for medically and socially complex people with blood cancer. QI & EBM expert. Views my own. She/her.🍁

◷ Joined March 2020▧ 118 Photos and videos
Matt Burke avatar
⟳ Lisa Hicks retweeted
Matt Burke@MattBurkeMD·Feb 4

It is so painful to share the news of @FralickMike sudden and unexpected passing 💔 Mike was an amazing, inspiring and generous person who touched the lives of many. As we mourn, please share and consider supporting his wife and 2-year-old daughter. gofund.me/236771146

ASH avatar
⟳ Lisa Hicks retweeted
ASH@ASH_hematology·Jan 28

ASH has released new Clinical Practice Guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening bone marrow disorder. The guidelines present 12 evidence-based recommendations designed to help clinicians improve diagnosis. ow.ly/OMEV50Y4S71

1:33
Amanda Gorman avatar
⟳ Lisa Hicks retweeted
Amanda Gorman@TheAmandaGorman·Jan 26

To the x bots bashing my poem for its format to avoid the relevancy of its content: the verse shape is inspired by Minneapolis itself. Stop griping over the structure of a poem and funnel that critical energy towards the federal agents executing American citizens.

Post attachment

Amanda Gorman @TheAmandaGorman Jan 25

Post attachment
ASH avatar
⟳ Lisa Hicks retweeted
ASH@ASH_hematology·Jan 21

From med student to fellow, Allison Taylor, MD, has received funding from ASH every step of the way! ASH can support your #hematology career, too. All you have to do is apply by Feb. 2: ow.ly/VtMh50XKYkQ #ASHAwards

0:32
Samer Al Hadidi, MD,MS,FACP avatar
⟳ Lisa Hicks retweeted
Samer Al Hadidi, MD,MS,FACP@HadidiSamer·Jan 17

#mmsm Every cancer deserves this level of progress (Great news to the myeloma field as well as the patients) ✅ 5-year relative survival has increased dramatically from 32% in the mid-1990s to 62% in 2015-2021 (and certainly better nowadays) ⭐️This represents one of the largest survival gains among high-mortality cancers⭐️ 🛑Estimated new cases in 2026: 36,000 total ✅ 5-year survival is virtually equal across races - 62% (White) vs 63% (Black) 👏 ⭐️One of the FEW cancers with no survival disparity, proof that when breakthrough treatments reach everyone, equity IS achievable⭐️ And yes, myeloma is a curable malignancy for some patients, the goal is to make it curable for most

Post attachment
Rahul Banerjee, MD, FACP avatar
⟳ Lisa Hicks retweeted
Rahul Banerjee, MD, FACP@RahulBanerjeeMD·Jan 13

Excellent to see OS benefit of CARTITUDE-4 (from #IMS24) now in @TheLancetOncol Only 2 modern Tx in MM have shown PFS, OS, & QOL ⬆️ in Ph3 trials; cilta-cel is one of them 👏 Clever Suppl Figure: almost more noticeable than if on one figure. OS best when CAR-T used early!

Post attachment

Cilta-cel in len-refractory MM (CARTITUDE-4 update). With 33.6-month f/u, there's continuing PFS benefit, and now a significant improvement in OS with cilta-cel #mmsm #bmtsm @H_Einsele @DrRakeshPopat thelancet.com/journals/lanon…

Rahul Banerjee, MD, FACP avatar
⟳ Lisa Hicks retweeted
Rahul Banerjee, MD, FACP@RahulBanerjeeMD·Jan 12

Such a privilege to be on @ASCO 🇺🇸 🇨🇦 myeloma guidelines led by @LisaHicksMD @jmikhaelmd Biggest pearl 👇 Most important part of discussions about CAR-T, tec-dara, etc isn’t what I say… … it’s what patient & loved one say after I present options! No right answer for all.

Post attachment

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline | Journal of Clinical Oncology @ASCO @JCO_ASCO #mmsm ➡️ ascopubs.org/doi/pdf/10.1200… @LisaHicksMD @jmikhaelmd @HiraSMian @RahulBanerjeeMD @bdermanmd @myelomaMD @SusanBal9 @MyelomaTeacher @TomBmt133 @Ccostello7 Great team work resulted in a living guidelines for treating multiple myeloma 👇 @utswcancer @HemOncFellows @ASCOTECAG @IMFmyeloma @HealthTree

Post attachment
Samer Al Hadidi, MD,MS,FACP avatar
⟳ Lisa Hicks retweeted
Samer Al Hadidi, MD,MS,FACP@HadidiSamer·Jan 7

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline | Journal of Clinical Oncology This is a living guideline 🌟 ➡️ ascopubs.org/doi/10.1200/JCO… @JCO_ASCO @ASCO @HadidiSamer @jmikhaelmd @LisaHicksMD #mmsm 🧵

Lisa Hicks avatar
Lisa Hicks@LisaHicksMD·Jan 7

The myeloma world moves fast! The new ASCO-CCO Myeloma Living Guideline will be updated as the evidence evolves. Check it out. ascopubs.org/doi/10.1200/JCO… @LisaHicksMD @jmikhaelmd @HiraSMian @RahulBanerjeeMD @bdermanmd @myelomaMD @SusanBal9 @MyelomaTeacher @JCO_ASCO @ASCO

Lisa Hicks avatar
Lisa Hicks@LisaHicksMD·Jan 7

Facing a difficult treatment decision in myeloma? Check out the ASCO-CCO Myeloma Treatment Guideline. ascopubs.org/doi/10.1200/JCO… @jmikhaelmd @RahulBanerjeeMD @myelomaMD @HadidiSamer @HiraSMian @bdermanmd @myelomateacher